Spyre Therapeutics (SYRE) EBT Margin (QoQ) (2015 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2.22 Mn |
| Mar 31, 2023 | 185,873.00 |
| Dec 31, 2022 | -58,153.00 |
| Sep 30, 2022 | -702,919.00 |
| Jun 30, 2022 | -177,611.00 |
| Mar 31, 2022 | -123,367.00 |
| Dec 31, 2021 | -39,145.00 |
| Sep 30, 2021 | -11,286.00 |
| Jun 30, 2018 | 14,097.00 |
| Mar 31, 2018 | -9,981.00 |
| Dec 31, 2017 | 18,672.00 |
| Sep 30, 2017 | -17,587.00 |
| Jun 30, 2017 | 18,743.00 |
| Mar 31, 2017 | -19,630.00 |
| Dec 31, 2016 | 10,339.00 |
| Sep 30, 2016 | -14,729.00 |
| Jun 30, 2016 | 13,381.00 |
| Mar 31, 2016 | -27,716.00 |
| Dec 31, 2015 | 6,650.00 |
| Sep 30, 2015 | -27,635.00 |